Balsm Alofoq Medical Company

9620.SR · Healthcare · · SAR

22.90 SAR

+0.00 (0.00%)

● Updated 2026-09-07 20:32 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score SELL Short-term (Swing)

/ 100

Technical 33

Trend & RS 32

Momentum 31

Fundamental (0%) 56

Macro 59

Liquidity 58

Component	Score	Weight
Technical	33.3	40%
Trend & RS	31.7	20%
Momentum	31.0	20%
Fundamental	55.6	0%
Macro	59.4	15%
Liquidity	57.6	5%

Trade Setup

Entry	22.90
Stop Loss	22.52 (1.7%)
Target 1 (1:1)	23.28 (+1.7%)
Target 2 (2:1)	23.66 (+3.3%)

ATR(14)	0.19 (0.8%)
Risk per Share	0.38
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	66.2	+0.65
Momentum	31.0	-0.76
Quality	57.5	+0.30
Composite	51.6

Quality Scores

Piotroski F-Score 5 /9 — Average

✓ ✓ ✗ ✗ ✓ ✓ ✗ ✓ ✗

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score Insufficient Data

Valuation vs Peers Fair Value

Metric	Stock	Sector	vs Peers
P/E Ratio	29.0	22.0	+32% above
P/B Ratio	1.9	4.0	Below

Comparing against Healthcare median multiples.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

6.96

Market Price

22.90

Upside

-69.6%

Margin of Safety	-229.0%
Stage 1 PV (5yr FCF)	6,187,678
Terminal Value PV	11,213,814
Total Enterprise Value	17,401,492

Assumptions

Base FCF	1,580,000
Growth Rate (5yr)	3.0%
Terminal Growth	2.5%
Discount Rate (WACC)	12.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

22.76%

Full Kelly

11.38%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 38/100. Estimated win rate 51%, avg win 7.3%, avg loss 4.2%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary SELL

Bullish Signals

Bearish Signals

16.79

RSI(14)

-0.263

MACD

Relative Strength (RS) WEAK RS

/ 99

RS Rating

O'Neil filter: <80

RS vs TASI	→ FLAT (+4.8% vs TASI 3M)
RS vs Sector	UNDERPERFORMING (Healthcare)
RS New High	No (6d since high)
Sector Outperformance	-2.8% (3M)

RS Line — stock / TASI (90 bars)

← older newer →

RS vs TASI 50-day SMA of RS

WEAK RS: Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.

Technical Indicators

Indicator	Value	Signal
Rsi	16.79	OVERSOLD
Macd	-0.263	BEARISH
Ma Cross	24.17 / 25.42	DEATH CROSS
Trend Short		BELOW SMA50
Trend Long		BELOW SMA200
Bollinger		LOWER BAND
Volume	3.38x	HIGH

Key Levels

Level	Price
52-Week High	32.25
Bollinger Upper	26.05
SMA(200)	25.42
SMA(50)	24.17
SMA(20)	24.47
Current Price	22.90
Bollinger Lower	22.9
52-Week Low	22.00
ATR(14)	0.19

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

DISTRIBUTION A Confidence

75%

Buying Climax

Acc: 1.0 | Dist: 3.0 | Markup: 0.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-09-01	Normal	0.07x	Normal bar — no special VSA pattern
2026-09-02	Normal	3.18x	Normal bar — no special VSA pattern
2026-09-03	Normal	4.75x	Normal bar — no special VSA pattern
2026-09-06	Normal	4.75x	Normal bar — no special VSA pattern
2026-09-07	Normal	3.38x	Normal bar — no special VSA pattern

Ichimoku Cloud BEARISH

Line	Value	Status
Tenkan-sen (9)	23.95	Below Kijun
Kijun-sen (26)	23.95	Base line
Senkou A	23.95	Leading span A
Senkou B	23.95	Leading span B
Cloud	23.95 – 23.95	Bearish (Red)
Price vs Cloud	22.90	Below Cloud
Chikou Span	24.70	Bearish
Alignment Score	0/4	BEARISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE OFF No squeeze Momentum: BEARISH

BB: 22.9 – 26.05 | KC: 24.22 – 24.73

Divergences (last 60 bars)

No significant divergences detected in the last 60 bars.

Anchored VWAP

VWAP: 24.06 Anchor: 2026-04-20 (52w Low) BELOW AVWAP -4.8%

Heikin-Ashi Trend

BEARISH Full data via /api/advanced/9620.SR

Valuation

Metric	Value
Market Cap	57.25M
P/E (TTM)	28.99
Forward P/E	N/A
P/B	1.85
EPS	0.79

Financial Health

Metric	Value
Revenue Growth	3.0%
Profit Margin	9.7%
ROE	6.6%
Debt/Equity	4.90
Current Ratio	10.26
Dividend Yield	N/A
Payout Ratio	N/A
Beta	N/A

Trading Data

22.90

Open

22.90

Day High

22.90

Day Low

1.9K

Volume (2.6x avg)

Insider Activity

Insider transaction data is not available for Saudi-listed stocks.

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)